Optical and Biochemical Biomarkers in Early Pancreatic Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection
- Status
- UNKNOWN
- Phase
- NA
Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
IMX-110 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Shark Mouth Modified Pancreaticojejunostomy
- Status
- UNKNOWN
- Phase
- N/A
Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage?
- Status
- WITHDRAWN
- Phase
- NA
Two Chemotherapy Regimens Plus or Minus Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?
- Status
- WITHDRAWN
- Phase
- NA
Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
- Status
- RECRUITING
- Phase
- N/A
A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PENS or TENS for Pain in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
CAR T Cell Immunotherapy for Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial
- Status
- RECRUITING
- Phase
- PHASE2
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1